Hatteras Venture Partners Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 12
Professionals
  • Investments
  • 144
  • Portfolio
  • 46
  • Exits
  • 59
Exits

Hatteras Venture Partners General Information

Description

Founded in 2000, Hatteras Venture Partners is a venture capital firm based in Durham, North Carolina. The firm seeks to invest in the commercial services, healthcare devices and supplies, healthcare technology systems, pharmaceuticals and biotechnology, software, SaaS, life sciences, and oncology sectors operating in the United States.

Contact Information

Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 280 South Mangum Street
  • Suite 350
  • Durham, NC 27701
  • United States
+1 (919) 000-0000

Hatteras Venture Partners Investments (144)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Wildflower Health 08-Mar-2022 Later Stage VC 0000 Other Healthcare Technology Systems Generating Revenue 0000 00000000
0000.00 10-Feb-2022 00000 00000 00.00 Other Healthcare Technology Systems Generating Revenue 0000 00000000
0000 000000000000 02-Dec-2021 00000 00000 0000 Drug Discovery Generating Revenue
00000000 16-Nov-2021 00000 00000 000.00 Drug Discovery Startup
00000000000 08-Nov-2021 00000 00000 00.00 Biotechnology Generating Revenue 0000 00000
0000000 0000 19-Oct-2021 00000 00000 0000 Decision/Risk Analysis Generating Revenue
000000 000000 0000 23-Sep-2021 00000 00000 00000 Medical Records Systems Generating Revenue
00000 00000 13-Aug-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 0000 00000
RapidPulse (Therapeutic Devices) 23-Jun-2021 Early Stage VC 0000 Therapeutic Devices Startup
Veralox Therapeutics 10-Jun-2021 Early Stage VC 000.00 Drug Discovery Startup 00000000 0000000 00.0
You’re viewing 10 of 144 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hatteras Venture Partners Exits (59)

Company Name Exit Date Exit Type Exit Size
AN2 Therapeutics 25-Mar-2022 IPO 0000
000000 00000000000 10-Jan-2022 000 00 00000000
0000 0000000000 07-Jan-2022 000000000000000000
00000 00000 07-Jan-2022 000 0000
000 (0000000000000 04-Jan-2022 000000000000000000
000000000 15-Oct-2021 000000000000000000 00000
0000000 0000000 13-Sep-2021 000 00000
0000 30-Jun-2021 000 00000
Clinipace 28-Apr-2021 Merger/Acquisition 00000
Vindara 10-Mar-2021 Merger/Acquisition 000.00
You’re viewing 10 of 59 exits. Get the full list »

Hatteras Venture Partners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Hatteras Venture Partners‘s full profile, request access.

Request a free trial

Hatteras Venture Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Hatteras Venture Partners Team (24)

Name Title Deals Funds Boards Office
Clay Thorp Co-Founder & General Partner 00 0 0 Durham, NC
Christy Shaffer Ph.D General Partner 00 0 0 Durham, NC
Douglas Reed MD General Partner 00 0 0 Durham, NC
Kenneth Lee Jr. General Partner 0 0 0 Durham, NC
Robert Ingram General Partner 0 0 0 Durham, NC
You’re viewing 5 of 24 team members. Get the full list »